Huadong Medicine: Announcement regarding the approval notification for new drug clinical trials by the US FDA obtained by the wholly-owned subsidiary
Huadong Medicine: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Huadong Medicine: Legal Opinion of Zhejiang Tian Ce Law Firm on The First Extraordinary General Meeting of Shareholders of Huadong Medicine Co., Ltd. in 2024.
Huadong Medicine: Announcement Regarding the Reduction of Restricted Stocks Subject to Buyback and Cancellation, Decrease of Registered Capital and Notice to Creditors.
Huadong Medicine: Announcement regarding expanding the scope of operation, changing registered capital, and revising the "Articles of Association" (updated).
Huadong Medicine: Announcement Regarding Full Subsidiary Obtaining Approval Notice for Clinical Trials of Drugs.
Huadong Medicine: Announcement regarding the expansion of operations, changes to registered capital, and the revision of the company's articles of association (prior to updates).
Huadong Medicine: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Huadong Medicine: Announcement on changing employee representative supervisors
Huadong Medicine: Announcement on the receipt of a notice of acceptance of drug registration by a wholly-owned subsidiary
Huadong Medicine: Legal Opinion of Zhejiang Tianze Law Firm on the 2023 Annual General Meeting of Shareholders of Huadong Pharmaceutical Co., Ltd.
Huadong Medicine: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Huadong Medicine: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Huadong Medicine: 2023 Annual General Meeting of Shareholders Meeting Materials
Huadong Medicine: Notice on Wholly-owned Subsidiaries Receiving Notice of Acceptance of Medical Device Registration Applications
Huadong Pharmaceutical: Announcement on Wholly-owned Subsidiaries Obtaining US FDA Clinical Trial Approval Notice for New Drugs
Huadong Pharmaceutical: 2023 Annual Financial Report
Huadong Pharmaceutical: Report on the performance of supervisory duties of accounting firms by the Board of Auditors in 2023
Huadong Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Huadong Pharmaceutical: 2023 Internal Control Self-Evaluation Report
No Data